_Markets open today Β· Q2 FY27 results season_
β¬β¬β¬β¬β¬β¬β¬β¬β¬β¬β¬β¬β¬β¬β¬β¬β¬β¬β¬β¬
π *ECONOMY & POLICY*
β¬β¬β¬β¬β¬β¬β¬β¬β¬β¬β¬β¬β¬β¬β¬β¬β¬β¬β¬β¬
π *IIP growth slows to 6.7% in September*
Output eased from August’s revised 7.8%, with manufacturing up 7.6%, electricity and gas up 11.2% and mining down 6.2%.
Capital goods (+10.4%) and intermediate goods (+12.2%) stayed strong, while consumer non-durables (+1.4%) stayed weak.
π _Read: Business Today_
π£οΈ *Cabinet clears βΉ10,000 cr container manufacturing scheme*
The scheme runs to FY2040 and targets about 10x capacity, to 7.5 lakh TEUs, with 3,000 direct and 50,000+ indirect jobs.
It cuts import dependence in the shipping chain and supports steel and paint suppliers. _(substituted: business-standard.com not fetchable here; verified via SocialNews.XYZ)_
π _Read: SocialNews.XYZ_
π¦ *Cabinet okays βΉ7,395 cr rural scheme, βΉ1,856 cr sports-goods push*
The PM Viksit Gram Swaraj Yojana and the eight-year Khelo India manufacturing scheme were cleared alongside the DA hike.
Both are small-ticket next to the DA cost, and the sports scheme offers a turnover-linked incentive of up to 15% for βΉ10 cr+ investors.
π _Read: The Federal_
π *NPPA slashes MRPs on 543 cancer drug brands, up to 93%*
Palbopro (palbociclib, RPG Life Sciences) fell 93.3% to βΉ2,720 per unit, and the revised prices apply from 9 Nov. Innovator brands such as Keytruda and Avastin are unchanged.
Generic and biosimilar makers face margin pressure, while innovator pricing is untouched.
π _Read: Business Standard_
β¬β¬β¬β¬β¬β¬β¬β¬β¬β¬β¬β¬β¬β¬β¬β¬β¬β¬β¬β¬
π’ *COMPANIES*
β¬β¬β¬β¬β¬β¬β¬β¬β¬β¬β¬β¬β¬β¬β¬β¬β¬β¬β¬β¬
π *L&T Q2 profit jumps 33% on record orders*
PAT rose to βΉ5,202 cr on revenue of βΉ78,750 cr (+16%), and order inflow hit a record βΉ1.48 lakh cr, taking the order book to βΉ8.5 lakh cr.
EBITDA was flat at about βΉ6,845 cr, but the stock jumped over 6% on the order visibility.
π _Read: TradingView_
π° *Jio Platforms lists at 21% premium in India’s biggest IPO*
Shares debuted at βΉ1,358 against the βΉ1,119 issue price in the βΉ30,213 cr IPO, and Upstox’s headline says they settled about 4.5% higher.
The listing sets a high-water mark for large-cap IPO appetite.
π _Read: Upstox_
β¬β¬β¬β¬β¬β¬β¬β¬β¬β¬β¬β¬β¬β¬β¬β¬β¬β¬β¬β¬
π *GLOBAL & WORLD*
β¬β¬β¬β¬β¬β¬β¬β¬β¬β¬β¬β¬β¬β¬β¬β¬β¬β¬β¬β¬
π¦ *Fed holds at 3.75β4%, two dissent for a hike*
Cook and Hammack voted for a hike, the Fed offered little forward guidance, and markets now price a December increase.
Higher-for-longer US rates keep pressure on the rupee and FII flows. _(substituted: Business Standard Fed link not fetchable here; verified via CNBC)_
π _Read: CNBC_
https://www.cnbc.com/2026/10/28/fed-interest-rate-decision-october-2026.html
β¬β¬β¬β¬β¬β¬β¬β¬β¬β¬β¬β¬β¬β¬β¬β¬β¬β¬β¬β¬
_Compiled by InvestoScope Β· 29 Oct 2026_
